Literature DB >> 12094248

Antigen expression patterns reflecting genotype of acute leukemias.

O Hrusák1, A Porwit-MacDonald.   

Abstract

Multi-parameter flow cytometry, molecular genetics, and cytogenetic studies have all contributed to new classification of leukemia. In this review we discuss immunophenotypic characteristics of major genotypic leukemia categories. We describe immunophenotype of: B-lineage ALL with MLL rearrangements, TEL/AML1, BCR/ABL, E2A/PBX1 translocations, hyperdiploidy, and myc fusion genes; T-ALL with SCL gene aberrations and t(5;14) translocation; and AML with AML1/ETO, PML/RARalpha, OTT/MAL and CBFbeta/MYH11 translocations, trisomies 8 or 11 and aberrations of chromosomes 7 and 5. Whereas some genotypes associate with certain immunophenotypic features, others can present with variable immunophenotype. Single molecules (as NG2, CBFbeta/SMMHC and PML/RARalpha proteins) associated with or derived from specific translocations have been described. More often, complex immunophenotype patterns have been related to the genotype categories. Most known associations between immunophenotype and genotype have been defined empirically. Therefore, these associations should be validated in independent patient cohorts before they can be widely used for prescreening of leukemia. Progress in our knowledge on leukemia will show how the molecular-genetic changes modulate the immunophenotype as well as how the expressed protein molecules further modulate cell behavior.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12094248     DOI: 10.1038/sj.leu.2402504

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  28 in total

1.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

2.  BCR-ABL1 and CD66c exhibit high concordance in minimal residual disease detection of adult B-acute lymphoblastic leukemia.

Authors:  Gu-Sheng Tang; Jun Wu; Min Liu; Hui Chen; Shen-Glan Gong; Jian-Min Yang; Xiao-Xia Hu; Jian-Min Wang
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

3.  A case of therapy-related acute lymphoblastic leukemia with t(11;19)(q23;p13.3) and MLL/MLLT1 gene rearrangement.

Authors:  Byong-Joon Yoo; Myung-Hyun Nam; Hwa-Jung Sung; Chae-Seung Lim; Chang-Kyu Lee; Yun-Jung Cho; Kap-No Lee; Soo-Young Yoon
Journal:  Korean J Lab Med       Date:  2011-01

4.  Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.

Authors:  Ester Mejstrikova; Jana Volejnikova; Eva Fronkova; Katerina Zdrahalova; Tomas Kalina; Jaroslav Sterba; Yahia Jabali; Vladimir Mihal; Bohumir Blazek; Zdena Cerna; Daniela Prochazkova; Jiri Hak; Zuzana Zemanova; Marie Jarosova; Alexandra Oltova; Petr Sedlacek; Jiri Schwarz; Jan Zuna; Jan Trka; Jan Stary; Ondrej Hrusak
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

5.  Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors.

Authors:  Jesse Jaso; Deborah A Thomas; Krista Cunningham; Jeffrey L Jorgensen; Hagop M Kantarjian; L Jeffrey Medeiros; Sa A Wang
Journal:  Cancer       Date:  2011-03-01       Impact factor: 6.860

6.  High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells.

Authors:  Veronika Kanderova; Daniela Kuzilkova; Jan Stuchly; Martina Vaskova; Tomas Brdicka; Karel Fiser; Ondrej Hrusak; Fridtjof Lund-Johansen; Tomas Kalina
Journal:  Mol Cell Proteomics       Date:  2016-01-19       Impact factor: 5.911

7.  A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting.

Authors:  Ingo Schubert; Christian Kellner; Christoph Stein; Markus Kügler; Michael Schwenkert; Domenica Saul; Kristin Mentz; Heiko Singer; Bernhard Stockmeyer; Wolfgang Hillen; Andreas Mackensen; Georg H Fey
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

8.  Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.

Authors:  Thomas Burmeister; Nicola Gökbuget; Stefan Schwartz; Lars Fischer; Daniela Hubert; Annette Sindram; Dieter Hoelzer; Eckhard Thiel
Journal:  Haematologica       Date:  2009-08-27       Impact factor: 9.941

9.  Hematogones: a sensitive prognostic factor for Chinese adult patients with acute myeloid leukemia.

Authors:  L Li; R Fu; T Zhang; X Xie; J Liu; J Tao; J Song; H Liu; W Zhang; W Lu; Z Shao
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

10.  Pathway Analysis of Genome-wide Association Study in Childhood Leukemia among Hispanics.

Authors:  Ling-I Hsu; Farren Briggs; Xiaorong Shao; Catherine Metayer; Joseph L Wiemels; Anand P Chokkalingam; Lisa F Barcellos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-03-03       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.